Brief: Samir Patel Appointed Interim CEO For Akari Therapeutics

Akari Therapeutics

01/05/2024 13:44

May 1 (Reuters) - Akari Therapeutics PLC  AKTX.O :
    * SAMIR R. PATEL, M.D. APPOINTED INTERIM CEO FOR AKARI
THERAPEUTICS
    * AKARI THERAPEUTICS PLC - RACHELLE JACQUES WILL STEP DOWN
AS
AKARI'S CHIEF EXECUTIVE OFFICER
    * AKARI THERAPEUTICS PLC - MELISSA BRADFORD-KLUG WILL STEP
DOWN AS
AKARI'S CHIEF OPERATING OFFICER
    * AKARI THERAPEUTICS PLC - EXPECTS TO ACHIEVE COST SAVINGS
THROUGH
REDUCED CLINICAL TRIAL AND INFRASTRUCTURE COSTS

Source text for Eikon:  ID:nGNXblS37L 
Further company coverage:  AKTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))